BIOASIS TECHNOLOGIES INC., a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB platform technology for the delivery of therapeutics across the blood-brain barrier (“BBB”) and the treatment of central nervous system (“CNS”) disorders in areas of high unmet medical need, including brain cancers and neurodegenerative diseases, today announced the appointment of Dave Jenkins as Chief Financial Officer.
“On behalf of our Board of Directors and our management team, it is my pleasure to welcome Dave to Bioasis. Dave has a proven track record in finance and accounting, including financing transactions, business development, strategic planning, and guiding companies through significant growth. His contributions will be critical as we continue to execute on our mission to advance our internal pipeline and license our proprietary xB3™ platform technology,” said Deborah Rathjen, Ph.D., Bioasis’ Executive Chair.
Recommended AI News: Etherlite Is Giving ETL Tokens to Every ETH Wallet Holder; Biggest Airdrop Ever
Jenkins has previously worked at a number of technology and life sciences companies and brings diverse financial management experience in executing the strategic and financial plans of emerging companies.
Recommended AI News:Liquid Intelligent Technologies and Facebook Partner to Build a Fibre Network in the DRC
“I am delighted to join Bioasis at a time when the company is preparing to reach major milestones in its development,” said Jenkins. “I am excited by the potential of the Bioasis xB3™ platform technology and admire the team’s focus and vision on bringing transformational therapies to patients with brain cancers and neurological diseases. I look forward to contributing to Bioasis’ success and supporting its mission.”
“The Board and management thank our outgoing CFO, Ms. Christine Antalik, for her contribution to Bioasis over the past several years and wish her every success in future endeavours,” said Dr. Rathjen.
Recommended AI News: Sasol And IDC Formalise Partnership To Co-Develop South Africa’s Hydrogen Economy
Comments are closed.